文献速递心力衰竭与心肌病

射血分数保留的心力衰竭运动不耐受:用个体化氧路径分析诊断并排序病因

Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: Diagnosing and Ranking Its Causes Using Personalized O2 Pathway Analysis.
PubMed 文献 · Circulation · 2017-10-09

该研究对79例HFpEF患者和55例对照进行侵入性心肺运动试验,量化氧传输与利用的6个步骤。HFpEF患者峰值摄氧量降低34±2%,97%存在多步骤缺陷,纠正心脏输出和肌肉扩散能力的预测获益分别为7±0.5%和27±1%。

要点

  • HFpEF运动不耐受由氧路径多步骤缺陷导致,97%患者存在多步骤缺陷。
  • 心脏输出和骨骼肌氧扩散相对对照分别受损27±3%和36±2%。
  • 纠正单一缺陷的预测获益常较小,纠正肌肉扩散能力可改善27±1%。

核心结论

  • HFpEF运动能力受多个氧路径缺陷损害,包括心脏输出和骨骼肌扩散能力降低。
  • 疾病异质性重要来源是每位患者个体化的缺陷谱。
  • 个体化氧路径分析可识别最可能从治疗特定缺陷中获益的患者,但氧传输系统特性 favor 同时治疗多个缺陷(如运动训练)。

研究设计与样本

  • 研究纳入134例转诊行心肺运动试验的患者:79例HFpEF和55例对照。
  • 进行侵入性监测的心肺运动试验,测量运动中的血流动力学、血气和气体交换。
  • 量化每例HFpEF患者氧传输与利用的6个步骤,识别损害峰值摄氧量的缺陷步骤,并计算纠正缺陷的预期运动能力改善。

主要发现

  • HFpEF患者峰值摄氧量较年龄、性别和体重指数相似的对照降低34±2%(均值±标准误,P<0.001)。
  • 97%的HFpEF患者存在氧路径多步骤缺陷,缺陷身份和幅度差异广泛。
  • 心脏输出和骨骼肌氧扩散相对对照分别平均受损27±3%和36±2%(两者P<0.001)。
  • 纠正心脏输出的预测运动不耐受改善平均为7±0.5%,纠正肌肉扩散能力为27±1%。
  • 个体水平上,任一氧路径缺陷对运动能力的影响受合并缺陷强烈影响。

临床怎么用

  • 个体化氧路径分析可识别最可能从治疗特定缺陷中获益的HFpEF患者。
  • 氧传输系统特性 favor 同时治疗多个缺陷,如运动训练。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is a common syndrome with a pressing shortage of therapies. Exercise intolerance is a cardinal symptom of HFpEF, yet its pathophysiology remains uncertain. METHODS: We investigated the mechanism of exercise intolerance in 134 patients referred for cardiopulmonary exercise testing: 79 with HFpEF and 55 controls. We performed cardiopulmonary exercise testing with invasive monitoring to measure hemodynamics, blood gases, and gas exchange during exercise. We used these measurements to quantify 6 steps of oxygen transport and utilization (the O2 pathway) in each patient with HFpEF, identifying the defective steps that impair each one's exercise capacity (peak Vo2). We then quantified the functional significance of each O2 pathway defect by calculating the improvement in exercise capacity a patient could expect from correcting the defect. RESULTS: Peak Vo2 was reduced by 34±2% (mean±SEM, P<0.001) in HFpEF compared with controls of similar age, sex, and body mass index. The vast majority (97%) of patients with HFpEF harbored defects at multiple steps of the O2 pathway, the identity and magnitude of which varied widely. Two of these steps, cardiac output and skeletal muscle O2 diffusion, were impaired relative to controls by an average of 27±3% and 36±2%, respectively (P<0.001 for both). Due to interactions between a given patient's defects, the predicted benefit of correcting any single one was often minor; on average, correcting a patient's cardiac output led to a 7±0.5% predicted improvement in exercise intolerance, whereas correcting a patient's muscle diffusion capacity led to a 27±1% improvement. At the individual level, the impact of any given O2 pathway defect on a patient's exercise capacity was strongly influenced by comorbid defects. CONCLUSIONS: Systematic analysis of the O2 pathway in HFpEF showed that exercise capacity was undermined by multiple defects, including reductions in cardiac output and skeletal muscle diffusion capacity. An important source of disease heterogeneity stemmed from variation in each patient's personal profile of defects. Personalized O2 pathway analysis could identify patients most likely to benefit from treating a specific defect; however, the system properties of O2 transport favor treating multiple defects at once, as with exercise training.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Houstis NE, Eisman AS, Pappagianopoulos PP, et al. Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: Diagnosing and Ranking Its Causes Using Personalized O2 Pathway Analysis. Circulation. 2017. PMID: 28993402. doi:10.1161/CIRCULATIONAHA.117.029058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。